Soft Tissue Repair Global Market - Forecast to 2023
Muscles, ligaments, tendons, fat and connective tissue constitutes soft tissue, where as Bones, cartilage and dental enamel is considered to be hard tissues. Damage to these Soft tissues are repaired by procedures that include hernia repair, cardiac repair, breast reconstruction, dental reconstruction, skin repair, etc. It does not include procedures that involve whole organ transplant and tissue regeneration and consist of products that are essential for patients suffering with soft tissue injuries and damage. With the projected rise in aged population, sports injuries and increased number of medical procedures such as hernia repair, cardiac repair, vaginal sling procedures, dental reconstruction, skin repair, etc. The market is focused on growing with newer technology and improved products. According to IQ4I analysis, the soft tissue repair global market is expected to grow at high single digit CAGR reach $21,319.7 million by 2023. Factors driving the soft tissue repair market include, increase in aging population, increase in medical procedures and sports injuries along with technology advancements and growing investment potential in emerging markets are contributing to the growth of soft tissue repair global market. Lack of awareness, limited reimbursements and high cost of procedures are hampering the market growth. Advancement of technology with its wide application areas shows that soft tissue repair market has vast opportunities in the coming years.
Soft tissue repair global market is classified based on products, surgeries, applications, and geography. The products segment is divided into four segments i.e., meshes/tissue patches, fixation devices, cardiac repair devices and others. Where, the meshes/tissue patches are further classified into synthetic meshes (absorbable meshes and non-absorbable meshes) and biological meshes (allografts tissue patches and Xenograft). The fixation devices market included products such as suture anchors, interference screws and others. The cardiac repair devices market included products such as heart valves (mechanical heart valve, biologic heart valve) and others. While, the others market includes products such as cornea, otologic grafts, cardiac grafts and tendons and ligament grafts. Soft tissue repair market based on surgery is classified into open surgery and minimally invasive surgery (laparoscopy, arthroscopy, catheter based surgery and robotic surgery).
Based on application, the soft tissue repair products are segmented into hernia repair, dental reconstruction, vaginal sling procedure, skin repair, breast reconstruction, orthopedic (dural repair and sports medicine), cardiac repair (transcatheter aortic valve replacement, mechanical heart valve replacement, biological heart valve replacement, annuloplasty ring, MitraClip, occluders, stent grafts and cardiac tissue patches).
Based on geography soft tissue repair global market is classified as North America, Europe, Asia Pacific and Rest of the world. North America accounts for the highest market share followed by Europe. The steep rise in aging population, increase in medical procedures and sports injuries along with technology advancements and growing investment potential in emerging markets are driving factors of soft tissue repair products market. However, Asian countries especially China and India are the fastest growing regions with its growing demand for soft tissue repair products.
Major players in soft tissue repair market include Edwards Lifesciences (U.S.), Medtronic PLC (Ireland), Abbott Laboratories (U.S.), Arthrex Inc (U.S.), Johnson & Johnson (U.S.), C.R. Bard Inc, (U.S.), Allergan (Lifecell) (U.S.), Smith & Nephew (U.K.), Integra Lifesciences (U.S.), Livanova (U.K.), Zimmer Biomet (U.S.), Organogenesis (U.S.), etc.
The report provides an in-depth market analysis of the above-mentioned segments across the following regions: